Covariate effects and population pharmacokinetics of lamivudine in HIV-infected children-Reference-Cited by-同舟云学术

Covariate effects and population pharmacokinetics of lamivudine in HIV-infected children

Published:2014-04-22 Issue:5 Volume:77 Page:861-872
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Piana Chiara¹,Zhao Wei²³,Adkison Kimberly⁴,Burger David⁵,Jacqz-Aigrain Evelyne²³,Danhof Meindert¹,Della Pasqua Oscar¹⁶

Affiliation:

1. LACDR; Division of Pharmacology; Leiden University; Leiden The Netherlands

2. Department of Paediatric Pharmacology and Pharmacogenetics; Hôpital Robert Debré; Assistance Publique - Hôpitaux de Paris; Université Paris VII; Paris

3. Clinical Investigation Center CIC9202; INSERM; Paris France

4. Clinical Pharmacology Modelling & Simulation; GlaxoSmithKline; Research Triangle Park USA

5. Department of Pharmacy & Nijmegen Institute for Infection; Inflammation and Immunity (N4i); Radboud University Nijmegen Medical Centre; Nijmegen The Netherlands

6. Clinical Pharmacology Modelling & Simulation; GlaxoSmithKline; Stockley Park UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12247/fullpdf

Reference36 articles.

1. Clinical pharmacokinetics of lamivudine;Johnson;Clin Pharmacokinet,1999

2. Lamivudine for the treatment of HIV;Kumar;Expert Opin Drug Metab Toxicol,2010

3. Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. TheNational Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group;Lewis;J Infect Dis,1996

4. Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole;Moore;Clin Pharmacol Ther,1996

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of Lamivudine-loaded PLGA nanoparticles in the diagnosis of lung cancer: Preparation, characterization, radiolabeling with 99mTc and cell binding;Journal of Drug Delivery Science and Technology;2022-03

2. Comparison of three galenic forms of lamivudine in young West African children living with Human Immunodeficiency Virus;Antiviral Therapy;2021-11

3. Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis;Frontiers in Pharmacology;2021-10-08

4. Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV;Therapeutic Drug Monitoring;2019-08

5. Population pharmacokinetics of abacavir and lamivudine in severely malnourished human immunodeficiency virus‐infected children in relation to treatment outcomes;British Journal of Clinical Pharmacology;2019-07-07